Company intelligence
PAULING.AI
From Idea to Drug Molecule in Days
Biotechnology Research
11 employees
4 public signals
About PAULING.AI
Pauling.AI is an autonomous drug discovery platform that compresses early-stage research from months to days. Our AI agents orchestrate dozens of computational pipelines molecular dynamics, docking, structure prediction, and ADMET profiling, so medicinal chemists can focus on biology, not software. Built for pharma and biotech teams that need to move faster without sacrificing scientific rigor.
Verified activity
Signals from PAULING.AI
4 published signals
Presence & Recognition
PAULING.AI featured a conversation between Ceo Javier Tordable and Hugo Verli on how software development is changing.
Reported by PAULING.AI
Technology & Infrastructure
PAULING.AI automated most of its computational chemistry pipeline.
Reported by Javier Tordable
Presence & Recognition
PAULING.AI featured Hugo Verli and Javier Tordable in a clip discussing how language models are helping researchers day to day.
Reported by PAULING.AI
Research & Knowledge
PAULING.AI published a new Nature Medicine review examining 20 years of induced pluripotent stem cell (iPSC) technology and its evolution into a platform for disease modeling, drug discovery, and regenerative medicine.
Reported by PAULING.AI